This Article Full Text Full Text (PDF) All Versions of this Article: 97/3/236    most recent 01.RES.0000176530.66400.48v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gupta, H. Articles by White, C. R. Search for Related Content PubMed PubMed Citation Articles by Gupta, H. Articles by White, C. R. Related Collections Peripheral vascular disease Cardiovascular Pharmacology Lipid and lipoprotein metabolism Endothelium/vascular type/nitric oxide Cell biology/structural biology Growth factors/cytokines

(Circulation Research. 2005;97:236.)
© 2005 American Heart Association, Inc.

Molecular Medicine

Inhibition of Lipopolysaccharide-Induced Inflammatory Responses by an Apolipoprotein AI Mimetic Peptide

Himanshu Gupta^*, Lijun Dai^*, Geeta Datta, David W. Garber, Hernan Grenett, Yanbing Li, Vinod Mishra, Mayakonda N. Palgunachari, Shaila Handattu, Sandra H. Gianturco, William A. Bradley, G.M. Anantharamaiah, C. Roger White

From the Department of Medicine, Division of Cardiovascular Disease (H.G., L.D., H.G., C.R.W.), the Vascular Biology and Hypertension Program (L.D., C.R.W.), and the Atherosclerosis Research Unit (G.D., D.W.G., V.M., M.N.P., S.H., S.H.G., W.A.B., G.M.A.), University of Alabama at Birmingham; and the First Affiliated Hospital of Sun Yat-Sen University (Y.L.), Guangzhou, People’s Republic of China.

Correspondence to C. Roger White, Dept of Medicine, Vascular Biology and Hypertension Program, 1046 Zeigler Research Bldg, 703 S 19th St, Birmingham, AL 35294-0007. E-mail crwhite{at}uab.edu

Previous studies suggest that high-density lipoprotein and apoAI inhibit lipopolysaccharide (LPS)-induced inflammatory responses. The goal of the current study was to test the hypothesis that the apoAI mimetic peptide L-4F exerts antiinflammatory effects similar to apoAI. Pretreatment of human umbilical vein endothelial cells (HUVECs) with LPS induced the adhesion of THP-1 monocytes. Incubation of cells with LPS and L-4F (1 to 50 µg/mL) reduced THP-1 adhesion in a concentration-dependent manner. This response was associated with a significant reduction in the synthesis of cytokines, chemokines, and adhesion molecules. L-4F reduced vascular cell adhesion molecule-1 expression induced by LPS or lipid A, whereas a control peptide (Sc-4F) showed no effect. In contrast to LPS treatment, L-4F did not inhibit IL-1ß- or tumor necrosis factor-–induced vascular cell adhesion molecule-1 expression. The inhibitory effect of L-4F on LPS induction of inflammatory markers was associated with reduced binding of LPS to its plasma carrier molecule, lipopolysaccharide binding protein, and decreased binding of LPS to HUVEC monolayers. LPS and L-4F in HUVEC culture medium were fractionated by fast protein liquid chromatography and were localized to the same fractions, suggesting a physical interaction between these molecules. Proinflammatory responses to LPS are associated with the binding of lipid A to cell surface receptors. The current studies demonstrate that L-4F reduces the expression of inflammatory markers induced by LPS and lipid A and suggest that apoAI peptide mimetics may be useful in the treatment of inflammation associated with endotoxemia.

Key Words: lipopolysaccharide • inflammation • vascular cell adhesion molecule-1 • apolipoprotein AI mimetic peptide

This article has been cited by other articles:

				E. M. deGoma, R. L. deGoma, and D. J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2199 - 2211. [Abstract] [Full Text] [PDF]

				G. M. Anantharamaiah, V. K. Mishra, D. W. Garber, G. Datta, S. P. Handattu, M. N. Palgunachari, M. Chaddha, M. Navab, S. T. Reddy, J. P. Segrest, et al. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides J. Lipid Res., September 1, 2007; 48(9): 1915 - 1923. [Abstract] [Full Text] [PDF]

				P. Thaveeratitham, W. Plengpanich, W. Naen-Udorn, S. Patumraj, and W. Khovidhunkit Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro Innate Immunity, February 1, 2007; 13(1): 58 - 64. [Abstract] [PDF]

				G. Florvall, S. Basu, and A. Larsson Apolipoprotein A1 Is a Stronger Prognostic Marker Than Are HDL and LDL Cholesterol for Cardiovascular Disease and Mortality in Elderly Men J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1262 - 1266. [Abstract] [Full Text] [PDF]

				A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF]

				W.-Y. Zhang, E. Schwartz, Y. Wang, J. Attrep, Z. Li, and P. Reaven Elevated Concentrations of Nonesterified Fatty Acids Increase Monocyte Expression of CD11b and Adhesion to Endothelial Cells Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 514 - 519. [Abstract] [Full Text] [PDF]

				M. Navab, G.M. Anantharamaiah, and A. M. Fogelman An Apolipoprotein A-I Mimetic Works Best in the Presence of Apolipoprotein A-I Circ. Res., November 25, 2005; 97(11): 1085 - 1086. [Full Text] [PDF]

				J. Ou, J. Wang, H. Xu, Z. Ou, M. G. Sorci-Thomas, D. W. Jones, P. Signorino, J. C. Densmore, S. Kaul, K. T. Oldham, et al. Effects of D-4F on Vasodilation and Vessel Wall Thickness in Hypercholesterolemic LDL Receptor-Null and LDL Receptor/Apolipoprotein A-I Double-Knockout Mice on Western Diet Circ. Res., November 25, 2005; 97(11): 1190 - 1197. [Abstract] [Full Text] [PDF]